Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study
ConclusionsThis real-world study demonstrated the effectiveness of iGlarLixi for improving glycemic control and decreasing body weight in people with T2D who need to advance therapy from OADs or insulin.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Bosnia and Herzegovina Health | Croatia Health | Diabetes | Diabetes Type 2 | Endocrinology | Gastroenterology | Insulin | Lantus | Slovenia Health | Statistics | Study | Women